Please login to the form below

Not currently logged in
Email:
Password:

lorcaserin

This page shows the latest lorcaserin news and features for those working in and with pharma, biotech and healthcare.

Eisai agrees to pull obesity drug Belviq after safety alert

Eisai agrees to pull obesity drug Belviq after safety alert

The decision to withdraw Belviq (lorcaserin) and once-daily line extension Belviq XR from the US market stems from a clinical trial that was conducted at the request of the FDA ... The study was intended to check whether the drug was associated with any

Latest news

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Anthony Zook resigns as Vivus CEO Anthony Zook resigns as Vivus CEO

    This coup was led by investment group First Manhattan Co, which had attempted to replace the entire board of Vivus after Qsymia fell behind rival obesity drug Belviq (lorcaserin) from Arena

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....